208 related articles for article (PubMed ID: 28281227)
1. Patient preferences regarding atrial fibrillation stroke prophylaxis in patients at potential risk of atrial fibrillation.
Edwards NT; Greanya ED; I Fan Kuo ; Loewen PS; Culley CL
Int J Clin Pharm; 2017 Apr; 39(2):468-472. PubMed ID: 28281227
[TBL] [Abstract][Full Text] [Related]
2. Evaluating the Effect of a Patient Decision Aid for Atrial Fibrillation Stroke Prevention Therapy.
Loewen PS; Bansback N; Hicklin J; Andrade JG; Kapanen AI; Kwan L; Lynd LD; McClean A; MacGillivray J; Salmasi S
Ann Pharmacother; 2019 Jul; 53(7):665-674. PubMed ID: 30724102
[TBL] [Abstract][Full Text] [Related]
3. Assessment of Web-based education resources informing patients about stroke prevention in atrial fibrillation.
Pandya E; Bajorek BV
J Clin Pharm Ther; 2016 Dec; 41(6):667-676. PubMed ID: 27704588
[TBL] [Abstract][Full Text] [Related]
4. Apixaban versus Antiplatelet drugs or no antithrombotic drugs after anticoagulation-associated intraCerebral HaEmorrhage in patients with Atrial Fibrillation (APACHE-AF): study protocol for a randomised controlled trial.
van Nieuwenhuizen KM; van der Worp HB; Algra A; Kappelle LJ; Rinkel GJ; van Gelder IC; Schutgens RE; Klijn CJ;
Trials; 2015 Sep; 16():393. PubMed ID: 26340977
[TBL] [Abstract][Full Text] [Related]
5. Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban.
Potpara TS; Polovina MM; Licina MM; Stojanovic RM; Prostran MS; Lip GY
Adv Ther; 2012 Jun; 29(6):491-507. PubMed ID: 22684583
[TBL] [Abstract][Full Text] [Related]
6. Eligibility and preference of new oral anticoagulants in patients with atrial fibrillation: comparison between patients with versus without stroke.
Yoon CH; Park YK; Kim SJ; Lee MJ; Ryoo S; Kim GM; Chung CS; Lee KH; Kim JS; Bang OY
Stroke; 2014 Oct; 45(10):2983-8. PubMed ID: 25147329
[TBL] [Abstract][Full Text] [Related]
7. How are patients with atrial fibrillation approached and informed about their risk profile and available therapies in Europe? Results of the European Heart Rhythm Association Survey.
Potpara TS; Pison L; Larsen TB; Estner H; Madrid A; Blomström-Lundqvist C;
Europace; 2015 Mar; 17(3):468-72. PubMed ID: 25722478
[TBL] [Abstract][Full Text] [Related]
8. Non-vitamin K antagonist oral anticoagulants in cardiovascular disease management: evidence and unanswered questions.
Cheng JW; Barillari G
J Clin Pharm Ther; 2014 Apr; 39(2):118-35. PubMed ID: 24383983
[TBL] [Abstract][Full Text] [Related]
9. Prevention of stroke in patients with atrial fibrillation.
Olsson SB; Halperin JL
Semin Vasc Med; 2005 Aug; 5(3):285-92. PubMed ID: 16123916
[TBL] [Abstract][Full Text] [Related]
10. Novel oral anticoagulants in cardiovascular disease.
Gallego P; Roldán V; Lip GY
J Cardiovasc Pharmacol Ther; 2014 Jan; 19(1):34-44. PubMed ID: 24038020
[TBL] [Abstract][Full Text] [Related]
11. Effective practical management of patients with atrial fibrillation when using new oral anticoagulants.
Cox JL
Ann Med; 2015 Jun; 47(4):278-88. PubMed ID: 25850527
[TBL] [Abstract][Full Text] [Related]
12. Renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R(2)CHADS(2) index in the ROCKET AF (Rivaroxaban Once-daily, oral, direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (AnTicoagulation and Risk factors In Atrial fibrillation) study cohorts.
Piccini JP; Stevens SR; Chang Y; Singer DE; Lokhnygina Y; Go AS; Patel MR; Mahaffey KW; Halperin JL; Breithardt G; Hankey GJ; Hacke W; Becker RC; Nessel CC; Fox KA; Califf RM;
Circulation; 2013 Jan; 127(2):224-32. PubMed ID: 23212720
[TBL] [Abstract][Full Text] [Related]
13. High-sensitivity troponin T and risk stratification in patients with atrial fibrillation during treatment with apixaban or warfarin.
Hijazi Z; Wallentin L; Siegbahn A; Andersson U; Alexander JH; Atar D; Gersh BJ; Hanna M; Harjola VP; Horowitz JD; Husted S; Hylek EM; Lopes RD; McMurray JJ; Granger CB;
J Am Coll Cardiol; 2014 Jan 7-14; 63(1):52-61. PubMed ID: 24055845
[TBL] [Abstract][Full Text] [Related]
14. Novel oral anticoagulants in secondary prevention of stroke.
Diener HC; Easton JD; Hankey GJ; Hart RG
Best Pract Res Clin Haematol; 2013 Jun; 26(2):131-9. PubMed ID: 23953901
[TBL] [Abstract][Full Text] [Related]
15. Non-vitamin K antagonist oral anticoagulation agents in anticoagulant naïve atrial fibrillation patients: Danish nationwide descriptive data 2011-2013.
Olesen JB; Sørensen R; Hansen ML; Lamberts M; Weeke P; Mikkelsen AP; Køber L; Gislason GH; Torp-Pedersen C; Fosbøl EL
Europace; 2015 Feb; 17(2):187-93. PubMed ID: 25236181
[TBL] [Abstract][Full Text] [Related]
16. The ORBIT bleeding score: a simple bedside score to assess bleeding risk in atrial fibrillation.
O'Brien EC; Simon DN; Thomas LE; Hylek EM; Gersh BJ; Ansell JE; Kowey PR; Mahaffey KW; Chang P; Fonarow GC; Pencina MJ; Piccini JP; Peterson ED
Eur Heart J; 2015 Dec; 36(46):3258-64. PubMed ID: 26424865
[TBL] [Abstract][Full Text] [Related]
17. Apixaban for stroke prevention in atrial fibrillation: a review of the clinical trial evidence.
Yates SW
Hosp Pract (1995); 2011 Oct; 39(4):7-16. PubMed ID: 22056819
[TBL] [Abstract][Full Text] [Related]
18. [Preferences for oral anticoagulant treatment in the medium and long term prevention of stroke in non valvular atrial fibrillation].
González-Rojas N; Giménez E; Fernández MÁ; Heineger AI; Martínez JL; Villar J; Lizán L
Rev Neurol; 2012 Jul; 55(1):11-9. PubMed ID: 22718404
[TBL] [Abstract][Full Text] [Related]
19. Challenges and Treatment for Stroke Prophylaxis in Patients with Atrial Fibrillation in Mexico: A Review.
Alcocer L
Am J Cardiovasc Drugs; 2016 Jun; 16(3):171-82. PubMed ID: 26923792
[TBL] [Abstract][Full Text] [Related]
20. Values and preferences in oral anticoagulation in patients with atrial fibrillation, physicians' and patients' perspectives: protocol for a two-phase study.
Alonso-Coello P; Montori VM; Solà I; Schünemann HJ; Devereaux P; Charles C; Roura M; Díaz MG; Souto JC; Alonso R; Oliver S; Ruiz R; Coll-Vinent B; Diez AI; Gich I; Guyatt G
BMC Health Serv Res; 2008 Oct; 8():221. PubMed ID: 18954427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
